Journal article
The role of teprotumumab in chronic, clinically active thyroid eye disease
Eye (London), Vol.36(7), pp.1500-1501
07/2022
DOI: 10.1038/s41433-021-01904-4
PMCID: PMC9232635
PMID: 34983925
Abstract
no abstract | brief communication
Details
- Title: Subtitle
- The role of teprotumumab in chronic, clinically active thyroid eye disease
- Creators
- Caroline Y Yu - University of Iowa Hospital and Clinics, Department of Ophthalmology and Visual Sciences, Iowa City, IA, 52240, USABrittany A Simmons - University of Iowa Hospital and Clinics, Department of Ophthalmology and Visual Sciences, Iowa City, IA, 52240, USAChau M Pham - University of Iowa Hospital and Clinics, Department of Ophthalmology and Visual Sciences, Iowa City, IA, 52240, USAErin M Shriver - University of Iowa Hospital and Clinics, Department of Ophthalmology and Visual Sciences, Iowa City, IA, 52240, USA. erin-shriver@uiowa.edu
- Resource Type
- Journal article
- Publication Details
- Eye (London), Vol.36(7), pp.1500-1501
- DOI
- 10.1038/s41433-021-01904-4
- PMID
- 34983925
- PMCID
- PMC9232635
- NLM abbreviation
- Eye (Lond)
- ISSN
- 0950-222X
- eISSN
- 1476-5454
- Grant note
- name: Research to Prevent Blindness, New York, NY - unrestricted grant to the Department of Ophthalmology at the University of Iowa Hospitals and Clinics
- Language
- English
- Electronic publication date
- 01/04/2022
- Date published
- 07/2022
- Academic Unit
- Otolaryngology; Ophthalmology and Visual Sciences
- Record Identifier
- 9984209492202771
Metrics
8 Record Views